Reference health

Clinical relevance of high sensitivity C-reactive protein in cardiology

https://doi.org/10.1016/j.medici.2015.12.001
CiteStamped reference-health badge
47/47 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 47 checked references that resolve
resolves10.1155/2014/605810
C-Reactive Protein: Clinical and Epidemiological Perspectives
resolves10.1016/j.jacc.2013.05.016
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
resolves10.1016/j.repc.2012.02.018
Proteína C reativa de alta sensibilidade como biomarcador de risco na doença coronária
resolves10.1016/j.ijcard.2013.07.113
High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
resolves10.1016/j.carrev.2008.01.003
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients
resolves10.2174/157340209787314333
Inflammation: A Link Between Hypertension and Atherosclerosis
resolves10.2147/vhrm.2006.2.3.221
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
resolves10.1111/j.1540-8167.2010.01774.x
Update on the Association of Inflammation and Atrial Fibrillation
resolves10.1161/CIR.0b013e3182051bab
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary
resolves10.1016/j.cardfail.2008.10.030
Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review
resolves10.1007/s11239-008-0245-7
High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis
resolves10.2174/138920112798868764
Role of C-Reactive Protein in Acute Myocardial Infarction and Stroke: Possible Therapeutic Approaches
resolves10.2174/187231309787158253
Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
resolves10.4103/0976-500X.77091
Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
resolves10.1186/1741-7015-8-34
Biomarkers in acute myocardial infarction
resolves10.1093/eurheartj/ehs168
Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?
resolves10.2310/6650.2007.00023
Evaluation of C-Reactive Protein in Primary and Secondary Prevention
resolves10.1161/01.CIR.97.20.2007
C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction
resolves10.1056/NEJM200003233421202
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
resolves10.1016/S0140-6736(09)61717-7
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
resolves10.1016/S0140-6736(10)62174-5
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
resolves10.1093/ije/dyn217
Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts
resolves10.1017/S0266462309990870
Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: A health technology assessment report
resolves10.1161/CIRCULATIONAHA.106.649939
Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease
resolves10.3904/kjm.2012.82.1.45
Elevated hs-CRP in Patients with Stable Angina Pectoris
resolves10.1590/S0066-782X2011005000032
Proteína C-reativa e prognóstico em síndromes coronarianas agudas: revisão sistemática e metanálise
resolves10.1161/01.CIR.0000052939.59093.45
Markers of Inflammation and Cardiovascular Disease
resolves10.1093/eurheartj/ehp273
C-reactive protein improves risk prediction in patients with acute coronary syndromes
resolves10.1136/hrt.2009.174912
Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies
resolves10.1093/eurheartj/ehr236
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
resolves10.1016/j.jacc.2010.06.045
The Evolving Role of Inflammatory Biomarkers in Risk Assessment After Stent Implantation
resolves10.1016/j.carrev.2014.02.003
Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy
resolves10.1016/j.amjcard.2011.01.042
Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent Type in Patients With ST-Segment Elevation Myocardial Infarction Randomized to Bare Metal or Drug-Eluting Stenting During Primary Percutaneous Coronary Intervention
resolves10.1016/j.ahj.2005.07.004
Unraveling the pathophysiology of acute heart failure: An inflammatory proposal
resolves10.1161/CIRCULATIONAHA.104.508465
C-Reactive Protein in Heart Failure
resolves10.2174/1874192401105010188
High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease
resolves10.1536/ihj.53.306
High Sensitivity C-Reactive Protein Predicts Nonresponders and Cardiac Deaths in Severe Heart Failure Patients After CRT Implantation
resolves10.1016/j.amjcard.2008.02.066
Meta-Analysis of Association Between C-Reactive Protein and Immediate Success of Electrical Cardioversion in Persistent Atrial Fibrillation
resolves10.1038/jhh.2013.111
C-reactive protein and Hypertension
resolves10.1097/MBP.0b013e3283651d19
Increased echocardiographic epicardial fat thickness and high-sensitivity CRP level indicate diastolic dysfunction in patients with newly diagnosed essential hypertension
resolves10.1007/s10554-010-9609-0
Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis
resolves10.1016/j.ypmed.2005.02.002
CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers
resolves10.2337/dc09-1402
Relations of Dietary Magnesium Intake to Biomarkers of Inflammation and Endothelial Dysfunction in an Ethnically Diverse Cohort of Postmenopausal Women
resolves10.1186/1758-5996-3-24
Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials
resolves10.1902/jop.2008.080249
Inflammation, C‐Reactive Protein, and Atherothrombosis
resolves10.1016/S0828-282X(09)70715-9
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations
resolves10.1093/eurheartj/ehs092
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
The 4 references without a DOI — listed, not checked
no DOI — not checkedClinical profiles of rapid progression of coronary artery lesions from mild to severe stenosis during a short-term period
no DOI — not checkedAssociation between serum levels of Hs-CRP and LDL-C with degree of coronary artery stenosis in patients with stable angina pectoris
no DOI — not checkedC-reactive protein in acute coronary syndrome, looking back in order to move forward
no DOI — not checkedImpact of C-reactive protein on in-stent restenosis: a meta-analysis
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.medici.2015.12.001"><img src="https://citestamp.com/citestamped/10.1016/j.medici.2015.12.001/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.medici.2015.12.001/badge.svg)](https://citestamp.com/citestamped/10.1016/j.medici.2015.12.001)